A systematic review of infliximab in the treatment of early rheumatoid arthritis

References

• [ACR] American College of RheumatologyGuidelines for the management of rheumatoid arthritis: 2002 UpdateArthritis Rheum2002463284611840435
   PubMed Web of Science ®Google Scholar
• ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum198831315243358796
   PubMed Web of Science ®Google Scholar
• BarbieriMWongJBDrummondMThe cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UKPharmacoeconomics2005236071815960556
   PubMed Web of Science ®Google Scholar
• BoersMCombination therapy in rheumatoid arthritisLancet199935495210489981
   PubMed Web of Science ®Google Scholar
• BoersMVerhoevenACMarkusseHMRandomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisLancet1997350309189251634
   PubMed Web of Science ®Google Scholar
• BongartzTSuttonAJSweetingMJAnti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsJAMA200629522758516705109
   PubMed Web of Science ®Google Scholar
• BreedveldFCEmeryPKeystoneEInfliximab in active early rheumatoid arthritisAnn Rheum Dis2004631495514722203
   PubMed Web of Science ®Google Scholar
• CallahanLFThe burden of rheumatoid arthritis: facts and figuresJ Rheumatol Suppl1998538129666412
   PubMedGoogle Scholar
• CallegariPESchaibleTFBosciaJALETTERS: Risk of serious infections and malignancies with anti-tnf antibody therapy in rheumatoid arthritisJAMA200629622012202
   Web of Science ®Google Scholar
• CombeBLandeweRLukasCEular recommendations for the management of early arthritis: report of a task force of the European Standing Committee for international Clinical Studies Including therapeutics (ESCISIT)Ann Rheum Dis200666344516396980
   PubMed Web of Science ®Google Scholar
• DeeksJHigginsJAltmanDAldersonPGreenSHigginsJAnalysing and presenting results. The Cochrane Reviewers’ Handbook2004Chichester, UKJohn Wiley & Sons Ltd 4.2.2
   Google Scholar
• EdmondsJPScottDLFurstDEAntirheumatic drugs: a proposed new classificationArthritis Rheum19933633698452578
   PubMed Web of Science ®Google Scholar
• FelsonDTAmerican college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis Rheum199538727357779114
   PubMed Web of Science ®Google Scholar
• FeltsWYelinEThe economic impact of the rheumatic diseases in the United StatesJ Rheumatol198916867842527991
   PubMed Web of Science ®Google Scholar
• FinckhAMugica van HerckenrodeCLiangMLong-term impact of early aggressive treatment of rheumatoid arthritis. A meta-analysisArthritis Rheum200655In press
   PubMed Web of Science ®Google Scholar
• Goekoop-RuitermanYPde Vries-BouwstraJKAllaartCFClinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study):a randomized, controlled trialArthritis Rheum20055233819016258899
   PubMed Web of Science ®Google Scholar
• GraudalNTarpUJurikAGInflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progressionJ Rheumatol200027475710648017
   PubMed Web of Science ®Google Scholar
• JansenLMvan der Horst-BruinsmaIEvan SchaardenburgDPredictors of radiographic joint damage in patients with early rheumatoid arthritisAnn Rheum Dis200160924711557647
   PubMed Web of Science ®Google Scholar
• KobeltGEberhardtKGeborekPTNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern SwedenAnn Rheum Dis20046341014672883
   PubMed Web of Science ®Google Scholar
• KobeltGJonssonLYoungAThe cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT studyRheumatology (Oxford)2003423263512595631
   PubMed Web of Science ®Google Scholar
• M Lopez-OlivoZOPakCHA meta-analysis on the timing of therapeutic introduction of infliximab (IFX) and etanercept (ETN)Ann Rheum Dis200665Suppl II329 Annual European Congress of Rheumatology, Amsterdam FRI0141
   Google Scholar
• MichaudKWolfeFReduced mortality among RA patients treated with anti-TNF therapy and methotrexateAnn Rheum Dis200564Suppl III87 EULAR Vienna, Dis.
   Google Scholar
• PincusTAggressive treatment of early rheumatoid arthritis to prevent joint damageBull Rheum Dis199847279926484
   PubMedGoogle Scholar
• QuinnMAConaghanPGO’ConnorPJVery early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal:results from a twelve-month randomized, double-blind, placebo-controlled trialArthritis Rheum200552273515641102
   PubMed Web of Science ®Google Scholar
• Schering-Plough CorporationRemicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis [online]2006 URL: http://www.News-Medical.Net
   Google Scholar
• ScottDLSmithCKingsleyGJoint damage and disability in rheumatoid arthritis:an updated systematic reviewClin Exp Rheumatol2003215 Suppl 31S20714969046
   PubMed Web of Science ®Google Scholar
• SilmanAJSilmanAJHochbergMCRheumatoid arthritis. epidemiology of the rheumatic diseases2001OxfordOxford University Press3171
   Google Scholar
• SmolenJSHanCvan der HeijdeDInfliximab treatment maintains employability in patients with early rheumatoid arthritisArthritis Rheum2006547162216508932
   PubMed Web of Science ®Google Scholar
• SmolenJSvan der HeijdeDMSt ClairEWPredictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab:results from the ASPIRE trialArthritis Rheum2006547021016508926
   PubMed Web of Science ®Google Scholar
• St ClairEWvan der HeijdeDMSmolenJSCombination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trialArthritis Rheum20045034324315529377
   PubMed Web of Science ®Google Scholar
• TaylorPCSteuerAGruberJComparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritisArthritis Rheum20045011071615077292
   PubMed Web of Science ®Google Scholar
• TaylorPCSteuerAGruberJUltrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritisArthritis Rheum200654475316385521
   PubMed Web of Science ®Google Scholar
• van der HeijdeDHow to read radiographs according to the Sharp/van der Heijde methodJ Rheumatol200027261310648051
   PubMed Web of Science ®Google Scholar
• van Der KooijSMInduction of remission in patients with early rheumatoid arthritis (RA) initially treated with either prednisone or infliximab combination therapy [abstract]Arthritis Rheum200654SupplS302 abstract 658
   Google Scholar
• WelsingPMvan GestelAMSwinkelsHLThe relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritisArthritis Rheum20014420091711592361
   PubMed Web of Science ®Google Scholar
• WilskeKRHealeyLARemodeling the pyramid – a concept whose time has comeJ Rheumatol19891656572754660
   PubMed Web of Science ®Google Scholar
• WolfeFHawleyDJThe longterm outcomes of rheumatoid arthritis:Work disability:a prospective 18 year study of 823 patientsJ Rheumatol1998252108179818651
   PubMed Web of Science ®Google Scholar
• YoungADixeyJKulinskayaEWhich patients stop working because of rheumatoid arthritis? Results of five years’ follow up in 732 patients from the Early RA Study (ERAS)Ann Rheum Dis2002613354011874837
   PubMed Web of Science ®Google Scholar